title: Continuous subcutaneous insulin infusion pump treatment in children with type 1 diabetes mellitus.
abstract: Data were reviewed from 73 consecutive medical charts of children and adolescents with type 1 diabetes mellitus using insulin pumps for more than 6 months at The Hospital for Sick Children, Toronto, Canada. Statistically significant differences in HbA1c (-0.8%), body mass index (+1.45 kg/m2) and total daily dose of insulin (-0.23 U/kg/day) were found between the start of pump use and evaluation 6-30 months later. There was a close correlation between the HbA1c before and after 6-30 months of pump therapy.
authors.affiliation: Division of Endocrinology, Department of Pediatrics, The Hospital for Sick Children and University of Toronto, Canada.
authors.forename: Raphael
authors.initials: R
authors.lastname: Liberatore
authors.forename: Kusiel
authors.initials: K
authors.lastname: Perlman
authors.forename: Jennifer
authors.initials: J
authors.lastname: Buccino
authors.forename: Ana
authors.initials: A
authors.lastname: Artiles-Sisk
authors.forename: Denis
authors.initials: D
authors.lastname: Daneman
mesh_terms: D000293:Adolescent; D001786:Blood Glucose / Q000378:metabolism; D015992:Body Mass Index; D002648:Child; D002675:Child, Preschool; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D004868:Equipment Failure; D005260:Female; D005500:Follow-Up Studies; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D007328:Insulin / Q000008:administration & dosage / Q000627:therapeutic use*; D007332:Insulin Infusion Systems; D008297:Male; D016896:Treatment Outcome
chemical_list: D001786:Blood Glucose; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D007328:Insulin